The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The US Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

The company so far appears to be the frontrunner in the race against Pfizer and Novavax to bring a combination shot to the market. While Moderna does not have specific revenue projections for its ...

Pfizer’s and Moderna's vaccine has been updated over time to target currently circulating variants, most recently in August, and is recommended for everyone six months and older. Children ages ...

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have one big thing in common. Both companies have dominated the coronavirus vaccine market -- and aim to continue generating blockbuster revenue from ...

The case for Moderna Like Pfizer, Moderna also expects a slowdown in vaccine revenue this year. The biotech last year generated $18.4 billion in product sales.

Moderna Inc fired back at counterclaims by Pfizer Inc and BioNTech SE in a U.S. lawsuit over COVID-19 vaccines on Wednesday, arguing that Pfizer and BioNTech were "clearly aided" by Moderna's ...